Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy

Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy

Item
http://www.wikidata.org/entity/Q22000845
A review of UHMWPE wear-induced osteolysis: the role for early detection of the immune response.Development of macromolecular prodrug for rheumatoid arthritisDexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549)Macromolecular therapeuticsEarly detection and treatment of wear particle-induced inflammation and bone loss in a mouse calvarial osteolysis model using HPMA copolymer conjugates.The Evaluation of the Therapeutic Efficacy and Side Effects of a Macromolecular Dexamethasone Prodrug in the Collagen-Induced Arthritis Mouse ModelDexamethasone prodrug treatment prevents nephritis in lupus-prone (NZB × NZW)F1 mice without causing systemic side effects.Development of polymeric nanocarrier system for early detection and targeted therapeutic treatment of peri-implant osteolysis.Macromolecular prodrug of dexamethasone prevents particle-induced peri-implant osteolysis with reduced systemic side effects.Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes.Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis.Trojan horses and guided missiles: targeted therapies in the war on arthritis.Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids.HPMA-Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer.Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis.Early diagnosis of orthopedic implant failure using macromolecular imaging agents.Acid-Sensitive Sheddable PEGylated, Mannose-Modified Nanoparticles Increase the Delivery of Betamethasone to Chronic Inflammation Sites in a Mouse Model.
P2860

Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy

Item
http://www.wikidata.org/entity/Q22000845
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development of a macromolecula ...... sustained therapeutic efficacy
@ast
Development of a macromolecula ...... sustained therapeutic efficacy
@en
Development of a macromolecula ...... sustained therapeutic efficacy
@en-gb
Development of a macromolecula ...... sustained therapeutic efficacy
@nl
type
label
Development of a macromolecula ...... sustained therapeutic efficacy
@ast
Development of a macromolecula ...... sustained therapeutic efficacy
@en
Development of a macromolecula ...... sustained therapeutic efficacy
@en-gb
Development of a macromolecula ...... sustained therapeutic efficacy
@nl
prefLabel
Development of a macromolecula ...... sustained therapeutic efficacy
@ast
Development of a macromolecula ...... sustained therapeutic efficacy
@en
Development of a macromolecula ...... sustained therapeutic efficacy
@en-gb
Development of a macromolecula ...... sustained therapeutic efficacy
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921
P932
P3181
P356
P1433
P1476
Development of a macromolecula ...... sustained therapeutic efficacy
@en
P2093
P2860
P2888
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921
P932